FEDERALhearing transcript

Congressional Hearing on the Economic Impact of Diabetes

Original title: THE ECONOMIC IMPACT OF DIABETES

January 1, 2023

diabetes healthcare economics public health income inequality metabolic disease

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

The Frame

What this does

This hearing serves as a formal inquiry into the national economic burden of diabetes, which lawmakers are investigating as a primary driver of income inequality and long-term fiscal strain on the U.S. healthcare system.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

American public

The population is subject to potential future policy changes regarding diabetes prevention and healthcare funding.

Healthcare providers

Medical professionals and researchers are providing data that may influence federal health policy and research funding priorities.

What changed

Last recorded activity January 1, 2023.

What's next

Next step not available in the current record.

Summary

The Joint Economic Committee held a hearing on July 27, 2023, to examine the economic and societal costs of diabetes in the United States. Lawmakers and experts discussed the link between health outcomes, income inequality, and the rising prevalence of diabetes among both adults and children.

Key Facts

The hearing was held on July 27, 2023, in the Dirksen Senate Building.
Lawmakers identified a correlation between health issues, specifically diabetes, and income inequality in the United States.
Data cited during the hearing suggests that by the end of the decade, nearly half of American children may be classified as obese, increasing the risk of a subsequent rise in diabetes cases.
The committee heard testimony from experts in endocrinology, public health, and health economics.
The hearing was convened to explore the economic impact of diabetes beyond direct healthcare costs, including lost productivity.
Witnesses included representatives from the Navajo Nation, the American Diabetes Association, the American Enterprise Institute, and Baylor College of Medicine.

Frequently Asked Questions

Why is Congress studying the economic impact of diabetes?

Lawmakers are investigating how health outcomes, particularly diabetes, contribute to income inequality and affect national economic productivity.

What is the projected trend for childhood obesity mentioned in the hearing?

A cited report suggests that by the end of the current decade, nearly 50% of American children could be obese, which may lead to higher rates of diabetes.

Why It Matters

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Health as an Economic Indicator

Lawmakers are explicitly framing public health outcomes like diabetes as a primary variable in economic inequality research.

Joint Economic Committee

Connected Entities

personBuu Nygren“President of the Navajo Nation and hearing witness”Map →

organizationJoint Economic Committee“Congressional committee hosting the hearing”Map →

personMartin Heinrich“Chairman of the Joint Economic Committee”Map →

personMark A. Herman“Chief of Endocrinology, Diabetes, and Metabolism at Baylor College of Medicine”Map →

personDavid Schweikert“Vice Chairman of the Joint Economic Committee”Map →

personJanet Brown-Friday“President of Health Care and Education at the American Diabetes Association”Map →

personBenedic N. Ippolito“Senior Fellow at the American Enterprise Institute”Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100

Significance65
How much this matters to a regular citizen
Controversy10
Intensity of disagreement among stakeholders
Entertainment5
Compellingness for a non-policy-wonk reader
Buzz20
Current news / social attention level

Publisher tools